Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 2.49% vs -5.36% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 146.75% vs -233.42% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 19.87% vs -35.28% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 8.28% vs 9.02% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Towa Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 2.49% vs -5.36% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 9.56% vs 4.13% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 146.75% vs -233.42% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 120.10% vs -54.27% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 19.87% vs -35.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 10.77% vs 0.46% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 8.28% vs 9.02% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 16.30% vs 63.14% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






